Cargando…
Disseminated cutaneous leishmaniasis in a kidney transplant recipient
KEY CLINICAL MESSAGE: In this case of disseminated cutaneous leishmaniasis in our immunosuppressive patient who was a refractor to treatment with intra‐lesion Glucantime® and systemic L‐AmB, considering the good clinical response to oral miltefosine, this drug might be the best treatment option. ABS...
Autores principales: | Amiri, Rezvan, Farrokhnia, Mehrdad, Mousavi Mehdiabadi, Fatemeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264955/ https://www.ncbi.nlm.nih.gov/pubmed/37323282 http://dx.doi.org/10.1002/ccr3.7549 |
Ejemplares similares
-
Co‐infection of coronavirus disease 19 and cytomegalovirus in a kidney transplant recipient
por: Farrokhnia, Mehrdad, et al.
Publicado: (2023) -
Visceral Dissemination of Mucocutaneous Leishmaniasis in a Kidney Transplant Recipient
por: Marques, Nídia, et al.
Publicado: (2020) -
Presentation of AIDS with Disseminated Cutaneous and Visceral Leishmaniasis in Iran
por: Davarpanah, Mohammadali, et al.
Publicado: (2015) -
Cutaneous protothecosis in kidney transplant recipient()()
por: Godofredo, Valeria Romero, et al.
Publicado: (2020) -
Atypical presentation of cutaneous leishmaniasis in a renal transplant recipient successfully treated with allopurinol and fluconazole
por: Yaich, Soumaya, et al.
Publicado: (2013)